Data as of May 17
| +0.17 / +3.14%|
The 3 analysts offering 12-month price forecasts for Astex Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a +43.11% increase from the last price of 5.59.
The current consensus among 3 polled investment analysts is to Buy stock in Astex Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.